1,596 hedge funds and large institutions have $95.7B invested in Amgen in 2017 Q1 according to their latest regulatory filings, with 151 funds opening new positions, 679 increasing their positions, 576 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

4% more funds holding

Funds holding: 1,5371,596 (+59)

1.05% more ownership

Funds ownership: 78.07%79.12% (+1%)

33% less call options, than puts

Call options by funds: $1.14B | Put options by funds: $1.7B

Holders
1,596
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
79
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.14B
Puts
$1.7B
Net Calls
Net Calls Change

Top Buyers

1 +$7.63B
2 +$2.24B
3 +$584M
4
Barclays
Barclays
United Kingdom
+$245M
5
Goldman Sachs
Goldman Sachs
New York
+$161M

Top Sellers

1 -$1.34B
2 -$387M
3 -$149M
4
Primecap Management
Primecap Management
California
-$147M
5
O
OrbiMed
New York
-$147M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$169M
77
$164M
78
$162M
79
$159M
80
$159M
81
$153M
82
$151M
83
$142M
84
$142M
85
$137M
86
$137M
87
$136M
88
$136M
89
$135M
90
$129M
91
$123M
92
$122M
93
$121M
94
$116M
95
$115M
96
$114M
97
$112M
98
$112M
99
$112M
100
$111M